1. Home
  2. UPC vs CVKD Comparison

UPC vs CVKD Comparison

Compare UPC & CVKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Universe Pharmaceuticals Inc.

UPC

Universe Pharmaceuticals Inc.

N/A

Current Price

$3.62

Market Cap

2.1M

Sector

Health Care

ML Signal

N/A

Logo Cadrenal Therapeutics Inc.

CVKD

Cadrenal Therapeutics Inc.

N/A

Current Price

$7.91

Market Cap

20.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
UPC
CVKD
Founded
1998
2022
Country
China
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medicinal Chemicals and Botanical Products
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1M
20.7M
IPO Year
2021
2023

Fundamental Metrics

Financial Performance
Metric
UPC
CVKD
Price
$3.62
$7.91
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$32.00
AVG Volume (30 Days)
51.7K
64.9K
Earning Date
01-01-0001
11-10-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$19,293,003.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.51
$7.43
52 Week High
$31.35
$22.90

Technical Indicators

Market Signals
Indicator
UPC
CVKD
Relative Strength Index (RSI) 43.46 36.68
Support Level $3.95 $7.43
Resistance Level $4.54 $12.50
Average True Range (ATR) 0.33 1.05
MACD 0.00 -0.02
Stochastic Oscillator 14.56 10.31

Price Performance

Historical Comparison
UPC
CVKD

About UPC Universe Pharmaceuticals Inc.

Universe Pharmaceuticals Inc is a pharmaceutical company specializing in the manufacturing, marketing, sales and distribution of traditional Chinese medicine derivatives products targeting the elderly with the goal of addressing their physical conditions in the ageing process and promoting their general well-being. The company also sells biomedical drugs, medical instruments, Traditional Chinese Medicine Pieces, and dietary supplements manufactured by third-party pharmaceutical companies. Its products are under two categories namely treatment and relief for common chronic health conditions in the elderly designed to achieve physical wellness and longevity (Chronic Condition Treatments), and cold and flu medications.

About CVKD Cadrenal Therapeutics Inc.

Cadrenal Therapeutics Inc is developing tecarfarin, its drug candidate, for unmet needs in anticoagulation therapy. Tecarfarin is a late-stage novel oral and reversible anticoagulant (blood thinner) designed to prevent heart attacks, strokes, and deaths due to blood clots in patients with rare cardiovascular conditions requiring chronic anticoagulation.

Share on Social Networks: